Showing 1 - 3 results of 3 for search 'Jaekyung Cheon', query time: 0.01s Refine Results
  1. 1
    Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan

    Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospec... by Jaekyung Cheon, Shigeo Shimose, Hyung-Don Kim, Takashi Niizeki, Min-Hee Ryu, Tomotake Shirono, Baek-Yeol Ryoo, Hideki Iwamoto, Changhoon Yoo

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment

    Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment by Young Eun Chon, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do young Kim, Seong Gyu Hwang, Hong Jae Chon, Beom Kyung Kim

    Published 2023-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression

    Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression by Sook-Kyoung Heo, Eui-Kyu Noh, Yoo Kyung Jeong, Lan Jeong Ju, Jun Young Sung, Ho-Min Yu, Jaekyung Cheon, SuJin Koh, Young Joo Min, Yunsuk Choi, Jae-Cheol Jo

    Published 2019-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: